Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Paclitaxel resistance related to nuclear envelope structural sturdiness
Elizabeth R. Smith, Jing‐Quan Wang, Dong‐Hua Yang, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100881-100881
Closed Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

High-dimensional deconstruction of ovarian cancer at single-cell precision reveals HEBP2 that reshape the TIME and drive carboplatin resistance
Bikang Yang, Miao Dai
Translational Oncology (2024) Vol. 44, pp. 101917-101917
Open Access | Times Cited: 1
Cancer nuclear envelope rupture and repair in taxane resistance
Ana P. Xu, Lucy B. Xu, Elizabeth R. Smith, et al.
Medical Review (2024) Vol. 4, Iss. 6, pp. 522-530
Open Access | Times Cited: 1
A Novel NCI-H69AR Drug-Resistant Small-Cell Lung Cancer Mini-Tumor Model for Anti-Cancer Treatment Screening
Alandi van Niekerk, Krzysztof Wrzesinski, Dewald Steyn, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1980-1980
Open Access | Times Cited: 3
Reassessing specificity/selectivity of taxane-based chemotherapy
Elizabeth R. Smith, Zheshen Li, Zhe‐Sheng Chen, et al.
Cancer Insight (2023) Vol. 3, Iss. 1, pp. 37-48
Open Access | Times Cited: 3
Targeting the deubiquitinase USP2 for malignant tumor therapy (Review)
Shilong Zhang, Yi Guo, Shenjie Zhang, et al.
Oncology Reports (2023) Vol. 50, Iss. 4
Open Access | Times Cited: 2
Metabolomics profiling and chemoresistance mechanisms in ovarian cancer cell lines: Implications for targeting glutathione pathway
Pedro Alarcón, Andy J. Pérez, Karin Toledo-Oñate, et al.
Life Sciences (2023) Vol. 333, pp. 122166-122166
Closed Access | Times Cited: 2
A whole-genome CRISPR screen identifies the spindle accessory checkpoint as a locus of nab-paclitaxel resistance in pancreatic cancer cells
Priya Mondal, George Alyateem, Allison V. Mitchell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
3-Methyladenine potentiates paclitaxel-induced apoptosis and phosphorylation of cyclin-dependent kinase 1 at thr161 in nasopharyngeal carcinoma cell
XIAOQI WU, YECHUAN HE, Yeqin Yuan, et al.
Biocell (2024) Vol. 48, Iss. 5, pp. 861-872
Open Access
Discovery and Mechanistic Insights into Thieno[3,2-D]Pyrimidine and Heterocyclic Fused Pyrimidines Inhibitors Targeting Tubulin for Cancer Therapy
Yuxi Wang, Chengyong Wu, Lele Zhang, et al.
(2024)
Closed Access
A whole-genome CRISPR screen identifies the spindle accessory checkpoint as a locus of nab-paclitaxel resistance in a pancreatic cancer cell line
Priya Mondal, George Alyateem, Allison V. Mitchell, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Construction and Evaluation of BAL-PTX Co-Loaded Lipid Nanosystem for Promoting the Anti-Lung Cancer Efficacy of Paclitaxel and Reducing the Toxicity of Chemotherapeutic Drugs
Tao Chen, Yumeng Wei, Suyu Yin, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 7775-7797
Open Access
Anticancer effects of Erzhimaoling decoction in high-grade serous ovarian cancer in vitro and in vivo
Yang Li, Jingfang Liu, Jiejie Zhang, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access
Natural diterpene carrier-free hydrogel enhances antigen presentation and intensifies T cell activation for tumor immunotherapy
Xiang Zhang, Luping Yang, Wenmin Pi, et al.
Chemical Engineering Journal (2024), pp. 156383-156383
Closed Access
MCL1 Inhibitor Augmented the Anti‐Glioma Efficacy of Paclitaxel Utilizing a Multifunctional Cascade Nanodrug System
Rui Zhang, Si Zhang, Zhenyu Zhang, et al.
Advanced Functional Materials (2024)
Open Access
Integrated in silico‐in vitro profiling of the systematic response of paclitaxel and its analogues to clinical tubulin variations in gynecologic cancers: Implications for the molecular mechanism of acquired tumor chemoresistance
Wenxiao Lu, Lili Shen, Shijian Zhao
Journal of the Chinese Chemical Society (2024)
Closed Access
Tumor-Targeted Magnetic Micelles for Magnetic Resonance Imaging, Drug Delivery, and Overcoming Multidrug Resistance
H. Liu, Xidong Wu, Xuewen Fang, et al.
ACS Omega (2024) Vol. 9, Iss. 50, pp. 49566-49579
Closed Access
Small-molecule inhibitor of Fam20C in combination with paclitaxel suppresses tumor growth by LIF-JAK2/STAT3-modulated apoptosis in triple-negative breast cancer
Zhaoxin Yuan, Yongqi Zhen, Siwei Chen, et al.
Journal of the Taiwan Institute of Chemical Engineers (2023) Vol. 143, pp. 104673-104673
Closed Access | Times Cited: 1
New ruthenium(ii) complexes with cyclic thio- and semicarbazone: evaluation of cytotoxicity and effects on cell migration and apoptosis of lung cancer cells
Yasmim G. Gonçalves, Amanda Blanque Becceneri, Angélica E. Graminha, et al.
Dalton Transactions (2023) Vol. 52, Iss. 28, pp. 9590-9606
Closed Access | Times Cited: 1
The translation of a short open reading frame product within the human TUBA1B gene regulates cancer cell proliferation by importin-β
Yaling Tao, Xuefeng Bai, Yinjie Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Reduction-responsive supramolecular hybridized paclitaxel nanoparticles for tumor treatment
Yuhan Wang, Yingli Cui, Tinggeng Dai, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access
Targeting mitotic regulators in cancer as a strategy to enhance immune recognition
Mateusz Gregorczyk, Eileen E. Parkes
DNA repair (2023) Vol. 132, pp. 103583-103583
Open Access
Reassessing specificity/selectivity of taxane-based chemotherapy
Elizabeth R. Smith, Zheshen Li, Zhe‐Sheng Chen, et al.
Cancer Insight (2023) Vol. 2, Iss. 2
Open Access
Previous Page - Page 2

Scroll to top